Book-to-bill 1.32, channel inventory down to 18 weeks, ASPs up 2% with volume up 7%, and only one third of announced price increases have landed.
Thesis: Vishay is pricing into a full order book with the levers still mostly unused: two thirds of announced price increases are queued behind backlog repricing, and the Newport utilization ramp plus Korean and China foundry wafers in Q3 are supply arriving into demand management cannot see the end of. The market is pricing a component cycle; the operating margin print of 5.8% versus 1.4% a year ago with gross margin pulled forward a quarter says the pricing is structural to capacity, not seasonal. Own it while book-to-bill is above 1.2; the exit signal is backlog cancellations, not the current quarter.
Verdict: LONG — Conviction: MEDIUM
Catalyst: Q3: Korean and China foundry wafers start feeding AI MOSFET and diode shipments, Newport automotive PCNs clear monthly unlocking Idaho 8-inch capacity, and gross margin prints 24% against guided $945-975M revenue.
Key Risk: Backlog quality unwind. $1.9B is 6.1 months built partly on customers securing queue position, management concedes non-AI demand is "becoming increasingly concerning," and distribution shipments rose 15.6% sequentially against POS up only 4.7%.
The Tell: Unprompted, mid-script, Smejkal broke from the demand narrative: "Customers who are not AI-related, that demand is becoming increasingly concerning. These customers need to make sure they have a manufacturing spot in our queue." He framed it as escalations, but he volunteered that non-AI orders are queue-fear driven, which is the bear's backlog-quality thesis coming from the CEO's own mouth.
Friction Level: MODERATE_FRICTION — Both sides agree on the numbers: 1.32 B2B, $1.9B backlog, POS +20.5% y/y, inventory down 20 to 18 weeks. Disagreement is on backlog composition. Bull reads 52-week-plus AI orders as firm demand; bear reads them as queueing behavior from lead-time fear that unwinds first when supply catches up in H2 2026.
2026Q2 · Aug 5, 2026
3 of 5 readings agreed3 LONG · 2 HOLDRead the full call
Two Thirds of the Price Increases Haven't Hit the P&L Yet
Vishay is pricing into a full order book with the levers still mostly unused: two thirds of announced price increases are queued behind backlog repricing, and the Newport utilization ramp plus Korean and China foundry wafers in Q3 are supply arriving into demand management cannot see the end of. The market is pricing a component cycle; the operating margin print of 5.8% versus 1.4% a year ago with gross margin pulled forward a quarter says the pricing is structural to capacity, not seasonal. Own it while book-to-bill is above 1.2; the exit signal is backlog cancellations, not the current quarter.
Unprompted, mid-script, Smejkal broke from the demand narrative: "Customers who are not AI-related, that demand is becoming increasingly concerning. These customers need to make sure they have a manufacturing spot in our queue." He framed it as escalations, but he volunteered that non-AI orders are queue-fear driven, which is the bear's backlog-quality thesis coming from the CEO's own mouth.
Adjusted revenue $919M beat the top of guidance, operating margin 5.8% vs 2.6% prior quarter and 1.4% y/y, and the 24% gross margin target was pulled forward a full quarter to Q3 while raising the revenue guide to $945-975M.
ASPs up 2% sequentially and 2% y/y on 18% volume growth, with only one third of running part numbers having announced increases. Backlog repricing updates "rather quickly," so customers can't pull ahead of hikes: "it's hard for somebody to pull anything ahead."
Backlog $1.9B, up 18%, 6.1 months coverage, with AI orders placed beyond 52 weeks and customers forecasting 12 to 18 months out. Book-to-bill 1.32 overall, 1.40 passives, 1.5 Americas.
Same data read bearishly: orders beyond 52 weeks are queue-position buying, not consumption. Distribution shipments rose 15.6% q/q against POS up 4.7% q/q, and management watches for double ordering every quarter.
Management states plainly there is more AI demand it cannot supply near term. Newport utilization waits on the last of 10 automotive audits plus PCN approvals "taking a little time"; Korean/China foundry wafers only land in Q3; Germany 12-inch starts non-automotive production mid-2027.
$830M equity raise funds $400-440M of 2026 capex, half to the German 12-inch fab where equipment is installed, targeting engineering wafers by year-end. Backed by capital, not slides.
+72
CONFIDENT"Smejkal said "we're early in this upcycle" unprompted, twice, and walked through eight named margin levers with dates. Gross margin target pulled forward a quarter voluntarily. Only deflection was wafer counts: "we're not ready to share that at this time.""
Dense quantitative disclosure: segment B2B, POS by region, weeks of inventory, cash conversion cycle, capex by site, tariff accounting. Gaps: no AI revenue figure, no wafer counts, FCF guided negative, Q&A hedged on double ordering.
Q3: Korean and China foundry wafers start feeding AI MOSFET and diode shipments, Newport automotive PCNs clear monthly unlocking Idaho 8-inch capacity, and gross margin prints 24% against guided $945-975M revenue.
Backlog quality unwind. $1.9B is 6.1 months built partly on customers securing queue position, management concedes non-AI demand is "becoming increasingly concerning," and distribution shipments rose 15.6% sequentially against POS up only 4.7%.
The verdict is public. The case behind it is Pro: the forensic reading of guidance and language, the bull and bear cases, the red flags, and the play. It opens to everyone on Nov 3, 2026.